ArticlePsychology research and behavior management2026
Cognitive Mediation of Biopsychosocial Determinants of Quality of Life in Epilepsy.
Article in Psychology research and behavior management, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Epilepsy is a chronic neurological disorder with complex etiology and high recurrence rates, often leading to substantial impairment in patients' quality of life (QoL). Within the biopsychosocial (BPS) framework, multiple biological, psychological, and social factors interact to influence QoL. Cognitive dysfunction is common in epilepsy and may play a critical role in this process. This study aimed to investigate the mediating role of cognitive function in the relationship between BPS factors and QoL in patients with epilepsy. Patients and Methods: A total of 252 patients with epilepsy treated at the First Affiliated Hospital of Anhui Medical University between 2022 and 2024 were included. Participants aged 14-66 years were included, representing late adolescents and adults with epilepsy treated in a tertiary clinical setting. Demographic and clinical characteristics were collected using a self-designed questionnaire. Anxiety, depression, stigma, and social functioning were assessed using the Hamilton Anxiety Rating Scale (HAMA), Hamilton Depression Rating Scale (HAMD), Kilifi Stigma Scale for Epilepsy (KSSE), and Social Disability Screening Schedule (SDSS), respectively. Pearson correlation analysis was used to examine associations among BPS factors, cognitive function, and QoL. Mediation analysis was performed to evaluate the mediating effect of cognitive function. Results: Disease duration, number of anti-seizure medications, anxiety, depression, perceived stigma, and social functioning impairment were all significantly negatively correlated with both cognitive function and QoL (all p < 0.001). Mediation analysis demonstrated that cognitive function partially mediated the associations between each BPS factor and QoL, with all indirect effects reaching statistical significance. Conclusion: Cognitive function mediates the impact of various biopsychosocial (BPS) factors on the quality of life of patients with epilepsy. This finding suggests that clinical management should place greater emphasis on improving patients' cognitive function to enhance their overall quality of life.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.